Loading
Latest filing published 03 Jun 2022 for INVO Bioscience, Inc., €8,799.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
All filings by Rebecca Messina on record concern INVO Fertility, Inc., in the capacity of board member. In total, 3 filings cover trades dated from 11 May 2021 to 1 June 2022.
No open-market sale appears; the market trades are 1 purchase worth €8,799. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 2 share grants. In 2022 alone, the filings show 1 purchase and no sales.
The record was last updated on 3 June 2022 with an open-market purchase (€8,799) in INVO Fertility, Inc. Typically, a trade is published a median of 2 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations